HLB Therapeutics Co.,Ltd.
115450
Rang în acțiuni
#18257
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Preț acțiune
$2.02
Capitalizare de piață
$190.66M
Schimbare (1 zi)
7.96%
Schimbare (1 an)
-1.16%
Țară
KR
Tranzacționează HLB Therapeutics Co.,Ltd. (115450)
Categorie
Healthcare
Venituri pentru HLB Therapeutics Co.,Ltd. (115450)
Venituri în Oct 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale HLB Therapeutics Co.,Ltd., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru HLB Therapeutics Co.,Ltd. din 2016 până în 2026
Venituri la sfârșitul fiecărui an
| An | Venituri | Schimbă |
|---|---|---|
| 2025 | $48.26M | 29.15% |
| 2024 | $37.36M | -10.01% |
| 2023 | $41.52M | 23.56% |
| 2022 | $33.60M | -8.35% |
| 2021 | $36.66M | -7.29% |
| 2020 | $39.54M | -22.56% |
| 2019 | $51.06M | 30.46% |
| 2018 | $39.14M | 143.21% |
| 2017 | $16.09M | 9.57% |
| 2016 | $14.69M | 0.00% |
Venituri pentru companii similare sau concurente
| Companie | Venituri | Diferență de venituri | Țara |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $10.11B | - |
BE
|
|
| $6.02B | - |
NL
|
